J.D. Bos

9.4k total citations · 1 hit paper
123 papers, 6.9k citations indexed

About

J.D. Bos is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, J.D. Bos has authored 123 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Dermatology, 65 papers in Immunology and 32 papers in Immunology and Allergy. Recurrent topics in J.D. Bos's work include Dermatology and Skin Diseases (45 papers), Psoriasis: Treatment and Pathogenesis (32 papers) and Allergic Rhinitis and Sensitization (21 papers). J.D. Bos is often cited by papers focused on Dermatology and Skin Diseases (45 papers), Psoriasis: Treatment and Pathogenesis (32 papers) and Allergic Rhinitis and Sensitization (21 papers). J.D. Bos collaborates with scholars based in Netherlands, Germany and Denmark. J.D. Bos's co-authors include Martien L. Kapsenberg, E A Wierenga, Phyllis I. Spuls, W. Westerhof, Menno A. de Rie, Marcel B. M. Teunissen, M. Snoek, Hanne Jansen, S. R. Krieg and F.G.M. Snijdewint and has published in prestigious journals such as The Lancet, The Journal of Immunology and Journal of Clinical Epidemiology.

In The Last Decade

J.D. Bos

121 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.

1990 659 citations J.D. Bos et al. profile →

Peers

Countries citing papers authored by J.D. Bos

Since Specialization

Citations

This map shows the geographic impact of J.D. Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.D. Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.D. Bos more than expected).

Fields of papers citing papers by J.D. Bos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.D. Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.D. Bos. The network helps show where J.D. Bos may publish in the future.

Co-authorship network of co-authors of J.D. Bos

This figure shows the co-authorship network connecting the top 25 collaborators of J.D. Bos. A scholar is included among the top collaborators of J.D. Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.D. Bos. J.D. Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of COVID-19 outbreaks in long-term care facilities 2023 ·Journal of Hospital Infection ·(unknown), Michael Welton, J.D. Bos, (unknown), (unknown), (unknown), John F. Pearson, George Turabelidze, (unknown), (unknown), (unknown)	1
2	Provoking factors, including chemicals, in Dutch patients with vitiligo 2012 ·British Journal of Dermatology ·Charlotte Vrijman, (unknown), (unknown), Albert Wolkerstorfer, J.D. Bos, J.P.W. van der Veen, Rosalie M. Luiten	26
3	Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo 2011 ·British Journal of Dermatology ·Marije W. Kroon, (unknown), Bas S. Wind, (unknown), Albert Wolkerstorfer, Rosalie M. Luiten, J.D. Bos, Ronald B. Geskus, J.P.W. van der Veen	14
4	Excimer laser vs. clobetasol propionate 0·05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot 2010 ·British Journal of Dermatology ·Elian E. A. Brenninkmeijer, Phyllis I. Spuls, Robert Lindeboom, Allard C. van der Wal, J.D. Bos, Albert Wolkerstorfer	40
5	Diagnostic criteria for atopic dermatitis: a systematic review 2008 ·British Journal of Dermatology ·Elian E. A. Brenninkmeijer, M.E. Schram, Mariska Leeflang, J.D. Bos, Phyllis I. Spuls	157
6	Impact of childhood vitiligo on adult life 2008 ·British Journal of Dermatology ·May W. Linthorst Homan, J. de Korte, M.A. Grootenhuis, J.D. Bos, Mirjam A. G. Sprangers, J.P.W. van der Veen	59
7	Long-term efficacy of a single course of infliximab in hidradenitis suppurativa 2007 ·British Journal of Dermatology ·Jan R. Mekkes, J.D. Bos	85
8	CLinical experience acquired with the efalizumab (Raptiva^®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial 2006 ·British Journal of Dermatology ·Louis Dubertret, Wolfram Sterry, J.D. Bos, Sergio Chimenti, Stephen Shumack, (unknown), Neil H. Shear, Kim Papp, (unknown)	115
9	Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects 2006 ·British Journal of Dermatology ·Ivone Jakaša, Cindy M. de Jongh, Maarten M. Verberk, J.D. Bos, Sanja Kežić	93
10	Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands 2003 ·Clinical Therapeutics ·J.D. Bos	54
11	Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy☆, ☆☆ 2000 ·Journal of the American Academy of Dermatology ·M.D. Njoo, J.D. Bos, W. Westerhof	234
12	No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis 1999 ·Journal of the American Academy of Dermatology ·S. A. Brands, (unknown), J.D. Bos, Menno A. de Rie	36
13	The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens 1996 ·British Journal of Dermatology ·I.M. Zonneveld, Menno A. de Rie, Rob C. Beljaards, Hwanseok Rhee, J. Wuite, (unknown), J.D. Bos	61
14	Expression of the T-cell activation antigens CD27 and CD28 in normal and psoriatic skin 1996 ·Clinical and Experimental Dermatology ·Menno A. de Rie, Irina Cairo, René A. W. van Lier, J.D. Bos	23
15	Intrinsic regulators of complement activation in vitiligo 1994 ·Journal of Investigative Dermatology ·(unknown), I. Caroline Le Poole, Nidhi Puri, Robert M. Vodegel, W. Westerhof, J.D. Bos, Pranab K. Das, (unknown)	2
16	Linear connective tissue naevus of the proteoglycan type ('naevus mucinosus') 1994 ·British Journal of Dermatology ·(unknown), Th. M. Starink, (unknown), J.D. Bos	13
17	Review of the etiopathomechanism of vitiligo: A convergence theory 1993 ·Experimental Dermatology ·I. Caroline Le Poole, Pranab K. Das, R.M.J.G.J. van den Wijngaard, J.D. Bos, W. Westerhof	194
18	Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease 1990 ·British Journal of Dermatology ·J.H. Sillevis Smitt, Ron S. Weening, S. R. Krieg, J.D. Bos	31
19	Cyclosporin A levels in suction-blister fluid of patients with psoriasis treated systemically 1990 ·British Journal of Dermatology ·Marcus M. H. M. Meinardi, (unknown), J. Oosting, (unknown), Menno A. de Rie, J.D. Bos	8
20	Increased anthralin irritation response in vitiliginous skin 1989 ·Archives of Dermatological Research ·W. Westerhof, (unknown), S Pavel, J.D. Bos, Pranab K. Das, S. R. Krieg, A. H. Siddiqui	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact